Kian‐Huat Lim

9.7k total citations
97 papers, 4.2k citations indexed

About

Kian‐Huat Lim is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kian‐Huat Lim has authored 97 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 29 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Kian‐Huat Lim's work include Pancreatic and Hepatic Oncology Research (48 papers), Colorectal Cancer Treatments and Studies (13 papers) and Cancer Genomics and Diagnostics (12 papers). Kian‐Huat Lim is often cited by papers focused on Pancreatic and Hepatic Oncology Research (48 papers), Colorectal Cancer Treatments and Studies (13 papers) and Cancer Genomics and Diagnostics (12 papers). Kian‐Huat Lim collaborates with scholars based in United States, China and South Korea. Kian‐Huat Lim's co-authors include Christopher M. Counter, Louis M. Staudt, David F. Kashatus, Brooke Ancrile, Adrienne D. Cox, Andrea Wang‐Gillam, Channing J. Der, Brooke B. Ancrile, William G. Fairbrother and Donita C. Brady and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Kian‐Huat Lim

89 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kian‐Huat Lim United States	29	2.4k	1.6k	781	752	400	97	4.2k
Youngkyu Park South Korea	35	2.9k 1.2×	1.4k 0.9×	608 0.8×	1.0k 1.3×	394 1.0×	88	5.0k
Melanie Boerries Germany	38	2.8k 1.2×	1.3k 0.8×	572 0.7×	1.0k 1.4×	440 1.1×	164	4.5k
Philip H. Howe United States	46	3.7k 1.6×	1.6k 1.0×	788 1.0×	1.1k 1.4×	474 1.2×	104	5.2k
Dimitris Athineos United Kingdom	26	2.6k 1.1×	1.2k 0.8×	445 0.6×	996 1.3×	330 0.8×	36	3.7k
Adriana Eramo Italy	32	2.5k 1.1×	1.9k 1.2×	634 0.8×	1.1k 1.4×	326 0.8×	49	4.1k
Masahiro Aoki Japan	31	3.6k 1.5×	1.3k 0.8×	752 1.0×	824 1.1×	377 0.9×	71	4.9k
Ann Zeuner Italy	35	2.4k 1.0×	1.4k 0.9×	879 1.1×	867 1.2×	434 1.1×	72	4.3k
Gong Yang China	45	2.8k 1.2×	1.4k 0.9×	625 0.8×	1.5k 1.9×	432 1.1×	108	5.0k
You‐Hong Cui China	41	2.8k 1.2×	1.7k 1.0×	1.1k 1.3×	1.4k 1.8×	343 0.9×	95	4.8k
Daniel J. Lindner United States	41	3.2k 1.3×	1.5k 0.9×	1.3k 1.7×	1.1k 1.5×	482 1.2×	133	5.4k

Countries citing papers authored by Kian‐Huat Lim

Since Specialization

Citations

This map shows the geographic impact of Kian‐Huat Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kian‐Huat Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kian‐Huat Lim more than expected).

Fields of papers citing papers by Kian‐Huat Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kian‐Huat Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kian‐Huat Lim. The network helps show where Kian‐Huat Lim may publish in the future.

Co-authorship network of co-authors of Kian‐Huat Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Kian‐Huat Lim. A scholar is included among the top collaborators of Kian‐Huat Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kian‐Huat Lim. Kian‐Huat Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Itani, Malak, Xiuli Liu, Lulu Sun, et al.. (2025). Tailored Approaches in the Treatment of Patients With Colorectal Cancer Harboring Tropomyosin Receptor Kinase Fusion and Microsatellite Instability-High: A Case Report and Literature Review. JCO Precision Oncology. 9(9). e2400305–e2400305.

Dotan, Efrat, Paul J. Catalano, Leon Lenchik, et al.. (2024). A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer (GIANT): ECOG-ACRIN EA2186.. Journal of Clinical Oncology. 42(16_suppl). 4003–4003. 4 indexed citations

Lim, Kian‐Huat, Kristen Spencer, Rachael A. Safyan, et al.. (2024). Avutometinib/defactinib and gemcitabine/nab-paclitaxel combination in first-line metastatic pancreatic ductal adenocarcinoma: Initial safety and efficacy of phase 1b/2 study (RAMP 205).. Journal of Clinical Oncology. 42(16_suppl). 4140–4140. 9 indexed citations

Grierson, Patrick, Rama Suresh, Benjamin Tan, et al.. (2023). A Pilot Study of Paricalcitol plus Nanoliposomal Irinotecan and 5-FU/LV in Advanced Pancreatic Cancer Patients after Progression on Gemcitabine-Based Therapy. Clinical Cancer Research. 29(23). 4733–4739. 7 indexed citations

Grierson, Patrick, Rama Suresh, Benjamin Tan, et al.. (2023). A pilot study of liposomal irinotecan plus 5-FU/LV combined with paricalcitol in patients with advanced pancreatic cancer whose disease progressed on gemcitabine-based therapy.. Journal of Clinical Oncology. 41(16_suppl). e16263–e16263. 1 indexed citations

Zhang, Daoxiang, Varintra E. Lander, Xiuting Liu, et al.. (2022). IRAK4 Signaling Drives Resistance to Checkpoint Immunotherapy in Pancreatic Ductal Adenocarcinoma. Gastroenterology. 162(7). 2047–2062. 33 indexed citations

Hidalgo, Manuel, Rocio García‐Carbonero, Kian‐Huat Lim, et al.. (2022). A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas. Cancer Research Communications. 2(11). 1326–1333. 5 indexed citations

Fields, Ryan C., et al.. (2021). Combined Systemic and Hepatic Artery Infusion Pump Chemo-Therapy as a Liver-Directed Therapy for Colorectal Liver Metastasis-Review of Literature and Case Discussion. Cancers. 13(6). 1283–1283. 9 indexed citations

Bansod, Sapana, et al.. (2021). Oncogenic KRAS-Induced Feedback Inflammatory Signaling in Pancreatic Cancer: An Overview and New Therapeutic Opportunities. Cancers. 13(21). 5481–5481. 12 indexed citations

10.

Khurana, Namrata, Daoxiang Zhang, Lin Li, et al.. (2020). TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations. Journal of Clinical Investigation. 130(9). 4771–4790. 24 indexed citations

11.

Lim, Kian‐Huat, Han Zhou, Hyun Yong Jeon, et al.. (2020). Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression. Nature Communications. 11(1). 3501–3501. 138 indexed citations

12.

Sanjeevaiah, Aravind, Rama Suresh, Rutika Mehta, et al.. (2020). P-131 Ramucirumab and irinotecan in patients with previously treated gastroesophageal adenocarcinoma: Interim analysis of a phase II trial. Annals of Oncology. 31. S132–S132. 1 indexed citations

13.

Yeo, Kee Thai, Sophie Octavia, Kian‐Huat Lim, et al.. (2019). Serratia marcescens in the neonatal intensive care unit: A cluster investigation using molecular methods. Journal of Infection and Public Health. 13(7). 1006–1011. 20 indexed citations

14.

Li, Qiong, Yali Chen, Daoxiang Zhang, et al.. (2019). IRAK4 mediates colitis-induced tumorigenesis and chemoresistance in colorectal cancer. JCI Insight. 4(19). 31 indexed citations

15.

Jiang, Hongmei, Ming Xu, Lin Li, et al.. (2018). Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models. Molecular Cancer Therapeutics. 17(10). 2144–2155. 32 indexed citations

16.

Zhang, Daoxiang, Lin Li, Hongmei Jiang, et al.. (2018). Tumor–Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer. Cancer Research. 78(7). 1700–1712. 145 indexed citations

17.

Lee, Yi-Shan, Jingxia Liu, Ravi Vij, et al.. (2017). Lack of a Prognostic Impact of the MyD88 L265P Mutation for Diffuse Large B Cell Lymphoma Patients Undergoing Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 23(12). 2199–2204. 7 indexed citations

18.

Zhang, Daoxiang, Lin Li, Hongmei Jiang, et al.. (2016). Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research. 23(7). 1748–1759. 60 indexed citations

19.

Brauer, David G., Matthew S. Strand, Dominic E. Sanford, et al.. (2016). Utility of a multidisciplinary tumor board in the management of pancreatic and upper gastrointestinal diseases: an observational study. HPB. 19(2). 133–139. 55 indexed citations

20.

Lee, Yi-Shan, Kian‐Huat Lim, Xingrong Guo, et al.. (2008). The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis. Cancer Research. 68(18). 7561–7569. 220 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact